report revenu million growth year-over-
year million consensu expect compani report non-
earn per share exceed street forecast
exclud one-tim charg million per share relat
tax reform gross profit margin decreas basi point rel
consensu estim estim oper margin
basi point
report total revenu intern growth versu estim
intern growth strong segment intern growth rel
estim growth segment support organ
gain recur diagnost revenu veterinari softwar
servic diagnost imag busi idxx rapid assay busi
post intern growth versu estim due strong
volum growth snap test specialti snap test well
continu progress regain share first-gener product global
sedivu instrument placement year-over-year total
instrument revenu saw intern growth strong placement gain
off-set defer revenu impact account standard
water segment post intern growth estim
year-over-year manag expect water busi post high
single-digit organ revenu gain idxx product anim segment
post intern growth versu intern growth estim
reflect higher project year-end govern program distributor
order solid gain recur revenu support growth idxx
pregnanc platform compani segment post intern
remain track releas snap fecal dx summer
compani also state current custom use snap
believ insul custom competit threat
leav half vulner abax upcom rapid test
earli tell realiz market share loss area
know follow vmx confer next week
manag rais earn per share rang
reflect benefit account chang come posit
currenc exchang rate effect addit organ busi growth
ep guidanc rang compar consensu expect
estim
increas ep estim overal
idxx oper perform continu strong compani
consider runway execut strategi launch new product
continu make oper invest impress idxx
busi model remain neutral share time
import pleas read disclosur disclaim page report
total debt total asset
inc northcoast researchannu incom statement market sale market interest incom tax share consolid extra incom extra average share ep extra growth growth compani report northcoast research estim disclosur
